We are live on ! Find out more
TA

Tamarack Advisers Portfolio holdings

AUM $2.12M
1-Year Est. Return 58.09%
This Fund
S&P 500
This Quarter Est. Return
+2.06%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$243M
AUM Growth
-$73.5M
Cap. Flow
-$66.1M
Cap. Flow %
-27.19%
Top 10 Hldgs %
48.94%
Holding
62
New
17
Increased
8
Reduced
19
Closed
14

Top Buys

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$9.14M
2
HUM icon
Humana
HUM
+$8.85M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.43M
4
VTRS icon
Viatris
VTRS
+$6.68M
5
CERS icon
Cerus
CERS
+$6.23M

Top Sells

Rank Stock Value
1
HSIC icon
Henry Schein
HSIC
+$27.7M
2
PDCO
Patterson Companies, Inc.
PDCO
+$12.4M
3
MSON
Misonix Inc
MSON
+$10.1M
4
PRGO icon
Perrigo
PRGO
+$10.1M
5
UTHR icon
United Therapeutics
UTHR
+$9.82M

Sector Composition

Rank Sector Weight
1 Healthcare 84.43%
2 Consumer Staples 3.88%
3 Consumer Discretionary 2.26%
4 Materials 1.99%
5 Technology 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVST icon
51
Envista
NVST
$4.44B
– –
-45,000
Closed -$1.88M
PFE icon
52
CALL
Pfizer
PFE
$143B
– –
-1,000
Closed -$156K
SPY icon
53
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
– –
-2,000
Closed -$2.06M
STE icon
54
Steris
STE
$22.3B
– –
-36,000
Closed -$7.35M
TALK icon
55
Talkspace
TALK
$874M
– –
-800,000
Closed -$2.92M
DMTK
56
DELISTED
DermTech, Inc. Common Stock
DMTK
– –
-85,000
Closed -$2.73M
NUVA
57
PUT
DELISTED
NuVasive, Inc.
NUVA
– –
-231
Closed -$143K
MSACW
58
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
– –
-66,665
Closed -$47K
MSON
59
DELISTED
Misonix Inc
MSON
– –
-400,000
Closed -$10.1M
1 2
3

Similar funds

SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

Tamarack Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, Tamarack Advisers held 62 positions worth $243M, down 23% from $317M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Tamarack Advisers withdrew a net $66.1M in Q4 2021, closing 14 positions and reducing 19 holdings. Its most notable exit was Misonix Inc, an estimated $10.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 85% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Tamarack Advisers opened a new position in Humana worth $9.28M.

  • Tamarack Advisers's largest Q4 2021 buy was Humana: 20,000 shares worth $9.28M.
  • Tamarack Advisers added most to Tenet Healthcare in Q4 2021, an estimated $9.14M increase.
  • Tamarack Advisers's biggest Q4 2021 reduction was Henry Schein, cutting an estimated $27.7M.
  • Tamarack Advisers fully exited Misonix Inc in Q4 2021, selling an estimated $10.1M.
  • Tamarack Advisers's ten largest holdings make up 49% of its $243M portfolio in Q4 2021.
  • Tamarack Advisers opened 17 new positions and closed 14 in Q4 2021.
  • Tamarack Advisers's portfolio value fell 23% quarter-over-quarter to $243M.

Based on Tamarack Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.